booksshare.net -> -> -> . -> " " -> 87

- .

. .: , 2007. 608 c.
ISBN 5-98657-009-
( ): pharmazeutischewirkstoffe1982.djvu
<< 1 .. 81 82 83 84 85 86 < 87 > 88 89 90 91 92 93 .. 345 >>

DBP 1096 353 (Schering AG; Anm. 11.7.1959).
DBP 1158 966 (Schering AG; Anm. 29.4.1961).
DBP 1189991 (Schering AG; Anm. 31.5.1963).
USP 3 234093 (Schering AG; ert. 8.2.1966; Anm. 24.4.1962; D-Prior. 29.4.1961). Ausgangsverbindung:
DBP 1119 266 (Schering AG; Anm. 18.12.1957).
USP2962 510 (Schering AG; ert. 29.11.1960; Anm. 9.12.1958; D-Prior. 18.12.1957). Weiteres Verfahren:
DBP 1183 500 (Schering AG; Anm. 12.10.1962).
Obersicht:
R. Wiechert, Z. Naturforsch. 196,944 (1964).
D: Andrwur"- (Schering) GB: Androcur® (Schering Chem.)
Diane® (Schering)-Komb. I: Androcur® (Schering)
Cytarabin 147-94-4 Cytostaticum
69-74-9 Hydrochlorid
4-amino-l-arabinofuranosyl-2-oxo-l,2-dihydropyrimidine
0-R
OH
Cytarabin
2,3,5-Tri-0-benzyl- 2,i-Dimethoxy-D-arabinofuranosyl- pyrimidin chlorid
DOT 13,475 (1977).
NL-Anm. 6 511420 (Merck & Co.; Anm. 1.9.1965; USA-Prior. 2.9.1964). USP 3 116282 (Upjohn; ert. 31.12.1963; Anm. 27.4.1960).
Cytarabin - Dacarbazin - Dactinomycin C/D 265
D: Alexan®(Mack, Illert.) J: Arabitin® (Sankyo)
Udicil® (Upjohn) Cylocide® (Nippon Kayaku)
F: Aracytine® (Upjohn) Cytosar® (Upjohn)
GB: Cytosar® (Upjohn) Iretin® (Torii)
I: Aracytin® (Upjohn) USA: Cytosar® (Upjohn)
Dacarbazin 4342-03-4 Cytostaticum
5-(3,3-dimethyl-l-triazeno)imidazole-4-carboxamide
h2n.
0=C^
NH2
5-Amino-
imidazol-4-
carboxamid
(СНг)2МН in CHjOH
NH2
5 - OiazoimidazoU 4-carboxamid
DOT 12,20(1976).
J. F. Shealy et al., J. Org. Chem. 27,2150 (1962).
F: Deticene® (Roger BeHon)
GB: DTIC(Dome) ‘
I:
НзС.
H3C
0=c'
\ NH2
Dacarbazin
DTI С (Miles)
USA: DTIC (Dome)
Dactinomycin
(Actinomycin;
Meractinomycin)
50-76-0
Antibioticum;
Cytostaticum
' actinomycin О
/Sa4
l-Рго L-Meval l-Рго L-Meval
Aus KuJturfiltraten von Actinomyces antibioticus und chromafographische Reinigung an A1203. USP 2 378 876 (Merck + Co.; ert. 1945; Anm. 1941).
D: Lyovac® (Sharp -+■ Dohme)
GB: Cosmegen Lyovac® (Merck Sharp ■+■ Dohme)
I: Cosmegen® (Merck Sharp -+■ Dohme) USA: Cosmegen® (Merck Sharp 4- Dohme)
266 D Danazol - Dantrolen
Danazol
17230-88-5
Hypophysenhemmstoff
17a-pregna-2,4-dien-20-yno[2,3-J)tsoxazol-17-ol
HCOOC2H5
NaOCaHs/jPyridm] HO —CH,
17a -Ethmyl -17/? - hydroxy- Ameisensaure-
3-oxo-i-androsten ethylester
NHjOH! NaO-CO-CHj /СН3СООН
->
Hydroxyl-
amin
DOT 11,52 (1975).
GB-P 905 844 (SterlingDrug; Laufzeit ab 1959; USA-Prior. 1958).
USP 3 135 743 (Sterling Drug; ert. 2.6.1964; Prior. 29.6.1960, 23.7.1958).
W. H. Pirkle et a)., J. Med. Chem. 6,1 (1963).
R. O. Clinton et al., J. Am. Chem. Soc. 83,1478 (1961).
D: Winobanin® (Winthrop) USA: Danocrine® (Winthrop)
GB: Danol® (Winthrop) Chronogyn® (Winthrop)
Dantrolen 7261 -97-4 Skelettmuskelrelaxans;
24868-30-0 Na-Salz, Tetrahydrat Antispasticum
l-[[5-(p-nitrophenyl)furfurylidene]amino]hydantoin
5-(4-Nitrophenyl)-2- 1-Aminohydantoin- ]_Dantrolen
furancarboxaidehyd Hydrochlorid
(vgl. Nitrofurantoirv Synlfcese. S. 641}
USP 3 415 821 (Norwich PharmacalCo.; ert. 10.12.1968; Anm. 7.9.1965). Я. R. Snyder Jr. et al., J, Med. Chem. 10, 807 (1967).
D: Dantamacrin® (Rohm Pharma) F: Damrium® (Oberwal)
GB: Dantrium® (Eaton Labs.) USA: Dantrium® (Eaton)
Dapson - Deanol-acetamidobenzoat - Debrisoquin D 267
Dapson 80-08-0 Chemotherapeuticum
(Diaphenylsulfon)
4,4'-diaminodiphenylsulfone <?r4,4'-sulfonyldianiline
N_*\^~C[ + Na2S -*
4,4'-Dinit r N—^3*—S°2—^3“—
K2Cr207/H2S04 Oder HOC!
4-Chlornitro- 4,4'-Dinitrodiphenylsulfid
benzol
o2n-</ NV-so3-</ >-N02 -i^hZSEL,
4,4'-Dinitrodiphenylsulfon
H2N—^ ^—SO2—^ ^—NH2 Dapson
b
2 H3C-CO-NH-<^^ + S02CIZ ^AICI^ » H3C-C0-NH-^^>-S02—l^^—NH-CO-Chb
Acetanilid Sulfuryl- 4,4'-Bis-(acetamido)-dipheny(suifon
chlorid
HCl _
-* Dapson
a E. C. Horning, Organic Synthesis Coll. Vol. Ill, S. 239. b USP2385899(Merck& Co.;ert. 1945;Prior. 1945).
GB: Maloprim®(Weilcome)-Komb. USA: Avlosulfon® (Ayerst)
J: Protogen® (Yoshitomi)
Deanol-acetamidobenzoat 3635-74-3 stimuians
(Oeanoli acetabenzoas)
* benzoic acid, p-acetamido-, compd. with 2-(dimethylamino)ethanol (1:1)
НзС\ /СНз
N-CH2-CH2-OH + HOOC-f У-NH-с
Нз</ \=/ ^
Deanol 4-Acetamidobenzoesaure (2-Dimethylaminoethanol)
НзС\+/Н /Г\ /СНз
n -оос-^ Vnh-c
Н3С/ SCH2-CH2-OH — о
Deanol-acetamidobenzoat
GB-P 879 259 (Riker; Anm. 1957; USA-Prior. 1956).
F: Diforene® (Choay) Pabenol® Complex (Gentili)-Komb.
1: Pabenol® (Gentili) USA: Deaner® (Riker)
Debrisoquin 1131-64-2 Antihypertonicum
581-88-4 Sulfat
3,4-dihydro-2(l//)-isoquinolinecarboxamidine
268 D Debrisoquin - Decamethonium-bromid - Deferoxamin
00*
1,2,3,4-Tetra-
hydro-
isochinoiin
NH
НзС-З-С^ * H2SOt
4nh2
S- Methylisothioharn-stoff-Sulfat
oo
NH
II
NH2
Debrisoquin
DOT 3, 93(1967).
Belg-P 629007 (Hoffmann-LaRoche; Anm. 28.2.1963; USA-Prior. 6.3.1962, 18.12.1962). DBP 1244 788 (Hoffmann-LaRoche; Anm. 25.2.1963; USA-Prior. 6.3.1962, 18.12.1962). W. Wenner, J. Med. Chem. 8,125 (1965).
<< 1 .. 81 82 83 84 85 86 < 87 > 88 89 90 91 92 93 .. 345 >>

c1c0fc952cf0704ad12d6af2ad3bf47e03017fed

, ?
2009 BooksShare.
.
Rambler's Top100

c1c0fc952cf0704ad12d6af2ad3bf47e03017fed